JAAD Expert Opinion Weighs Hedgehog Inhibitors in the Immunotherapy Era for Advanced BCC
JAAD published an expert opinion on October 8, 2026 comparing efficacy and tolerability of hedgehog pathway inhibitors for locally advanced basal cell carcinoma as immunotherapy reshapes the field.